*UO Malattie Cardiovascolari, Ospedale Santa Croce, Castelnuovo di Garfagnana, Italy; †Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Pisa, Italy; and ‡Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
J Cardiovasc Pharmacol. 2017 Nov;70(5):290-292. doi: 10.1097/FJC.0000000000000518.
Dyspnea and bradyarrhythmias are frequent adverse effects (AEs) of ticagrelor. AEs commonly occur within the first week of therapy, are dose related and usually mild, but sometimes they may cause drug discontinuation. Currently, the exact mechanisms of ticagrelor-related AEs have not been definitively explained. In addition to the prevalent theory of adenosine overload, other reasonable mechanism like a direct central stimulation hypothesis was suggested. We present a case of incessant Cheyne-Stokes respiration associated with heart rate instability in patient with congestive heart failure and non-ST-segment elevation myocardial infarction, supporting the use of aminophylline as a potential reversal agent of ticagrelor-related AEs.
呼吸困难和心动过缓是替格瑞洛常见的不良反应(AE)。AE 通常发生在治疗的第一周内,与剂量有关,通常是轻微的,但有时可能导致停药。目前,替格瑞洛相关 AE 的确切机制尚未明确解释。除了普遍存在的腺苷过载理论外,还提出了其他合理的机制,如直接中枢刺激假说。我们报告了一例充血性心力衰竭和非 ST 段抬高型心肌梗死患者持续出现 Cheyne-Stokes 呼吸和心率不稳定的病例,支持使用氨茶碱作为替格瑞洛相关 AE 的潜在逆转剂。